The share
Stock Exchange listing
XVIVO Perfusion is listed on Nasdaq Stockholm mid cap list. The share has been listed on Nasdaq Stockholm mid cap since November 28, 2016. The XVIVO Perfusion share was before that listed on Nasdaq First North since October 8, 2012.
ISIN-code: SE0004840718
Ticker: XVIVO
Trading lot: 1 share
Shareholders
According to Euroclear Sweden’s official share register as of March 31, 2019, the total number of shareholders were 5 410. The top 10 largest shareholders held approximately 49.9 percent of the shares.
| Shareholder | Shares | % |
|---|---|---|
| Bure, AB Equity | 4 205 504 | 15.9% |
| Swedbank ROBUR ny teknik BTI | 1 630 000 | 6.2% |
| Eccenovo AB | 1 470 662 | 5.6% |
| Fjärde AP-fonden | 1 250 000 | 4.7% |
| Norron Fonder | 1 241 485 | 4.7% |
| Oppenheimer | 1 000 000 | 3.8% |
| Thomas Olausson | 894 447 | 3.4% |
| Tredje AP-fonden | 530 238 | 2.0% |
| Försäkringsaktiebolaget, Avanza pension | 477 142 | 1.8% |
| Catella Fonder | 470 197 | 1.8% |
| Top 10 largest shareholders, total | 13 169 675 | 49.9% |
| Other shareholders | 13 232 821 | 50.1% |
| Total | 26 402 496 | 100% |
2012 – Allotment of acquisition cost XVIVO Perfusion decided by the Swedish Tax Agency.
In connection with Vitrolife’s distribution of the shares in Xvivo Perfusion AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB and 23% to Xvivo Perfusion AB.
Further information can be found on the Swedish Tax Agency’s website www.skatteverket.se or by using the links below:
Skatteverkets allmanna rad (SKV A 2012-28)
Skatteverkets meddelande (SKV M 2012-25)
2016 – The Swedish Tax Agency decided how to tax the Vivoline shares purchased by XVIVO Perfusion.
In connection with XVIVO Perfusion´s acquisition of Vivoline Medical AB the Swedish Tax Agency decided the tax treatment for the Vivoline shares purchased by XVIVO Perfusion AB.
Further information can be found on the Swedish Tax Agency’s website www.skatteverket.se or by using the links below:
Skatteverkets Brevsvar ang. XVIVOs köp av Aktier och Optioner i Vivoline
